Want to create an interactive transcript for this episode?
Podcast: CME
Episode: Anatomical Outcomes from the LIGHTSITE III Trial
Description:
Faculty: Diana V. Do, MD
Faculty: David Boyer, MD
This CME activity focuses on multiwavelength photobiomodulation (PBM), an emerging therapy indicated for the treatment of dry age-related macular degeneration (AMD). Hear from leading researchers and retina specialists about the mechanism of action, how it is administered, its efficacy and safety profile, therapeutic durability, which patients may benefit the most, and how PBM would fit into the AMD treatment paradigm.